Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India

An earlier open label, prospective, non-randomized, non-comparative, multi-centric study conducted within public health facilities in Bihar, India (CTRI/2012/08/002891) measured the field effectiveness of three new treatment regimens for visceral leishmaniasis (VL): single dose AmBisome (SDA), and c...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PLoS neglected tropical diseases 2019-09, Vol.13 (9), p.e0007726-e0007726
Hauptverfasser:	Goyal, Vishal, Burza, Sakib, Pandey, Krishna, Singh, Shambhu Nath, Singh, Ravi Shankar, Strub-Wourgaft, Nathalie, Das, Vidya Nand Rabi, Bern, Caryn, Hightower, Allen, Rijal, Suman, Sunyoto, Temmy, Alves, Fabiana, Lima, Nines, Das, Pradeep, Alvar, Jorge
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Amphotericin B - therapeutic use Antiprotozoal Agents - therapeutic use Biology and Life Sciences Child Child, Preschool Cohort Studies Cohorts Disease control Drug dosages Drug therapy Drug Therapy, Combination Evaluation Family medical history Feasibility studies Female Follow-Up Studies Funding Health care facilities Health facilities Hospitals Humans Identification India Infectious diseases Labels Leishmaniasis Leishmaniasis, Visceral - drug therapy Male Medical research Medicine and Health Sciences Miltefosine Organic chemistry Parasitic diseases Paromomycin Paromomycin - therapeutic use Patient outcomes Patients People and Places Phosphorylcholine - analogs & derivatives Phosphorylcholine - therapeutic use Public health Recurrence Software Supervision Treatment Outcome Tropical diseases Vector-borne diseases Visceral leishmaniasis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!